Delivery of Anticancer Drugs Using Polymeric Micelles Stabilized by Hydrogen-Bonding Urea Groups

Polymeric micelles comprising a hydrogen‐bonding core were formed from block copolymers with pendant urea groups and explored as drug delivery vehicles. The amphiphilic block copolymers were synthesized by organocatalytic ring opening polymerization (ROP) of urea‐functionalized cyclic carbonates from a poly(ethylene glycol) macroinitiator. The urea functionality was incorporated because its ability to increase the hydrophobic core's affinity toward polar organic compounds through intermolecular hydrogen bonding. Doxorubicin (DOX), a lipophilic anticancer drug with hydrogen‐bonding functionalities, was systematically incorporated into the micelle's hydrophobic interior via hydrogen bonding to the functionalized monomers. Micelles employing urea groups were found to more efficiently interact with DOX thus allowing increased drug loading capacity while maintaining a desirable micellular size. More importantly, while DOX‐loaded micelles were shown to kill HepG2 human liver carcinoma cell lines efficiently, all of the polymers were non‐cytotoxic. Hydrogen‐bonding urea groups were implemented within the hydrophobic domain of amphiphilic micelles.This non‐conventional approach improved micelle stability and doxirubicin loading capacity. The drug‐loaded micelles were then shown to effectively kill all cell lines tested, while the polymeric carrier exhibited no cytotoxicity.